DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

MRI Homepage

Hawaii takes aim at kidney disease with 7T preclinical MR system Will track changes in kidneys to determine disease origins

MR research raises the question: Is it time to ditch the necktie? Compressing the jugular vein and carotid artery reduces cerebral blood flow

The importance of breast MR screening for high-risk patients Experts weigh in on MR's emerging role in breast cancer diagnostics

All-optical ultrasound could pave way for combined MR-ultrasound imaging Three orders of magnitude faster than current optical systems

India hospital where man died in MR accident seeks new machine Adding a second scanner in addition to fixing the first raises concerns

MR okay for cardiac device patients – if done right Consulting with electrophysiologists is essential

Guerbet and IBM Watson to develop AI-based liver diagnostics solution Supports liver diagnostics in CT and MR

Canon showcases new 3T MR research system at meeting in France Generates images comparable to those acquired with 7T

Praxair in deal to sell European assets to Taiyo Nippon Sanso Move is dependent on the successful closing of the Praxair-Linde merger

MITA calls for timely exemption process for Section 301 tariffs Calls for exemption of medical imaging technology

Could also test new
anti-scarring treatments

Study finds MR can measure kidney scarring and predict future kidney function

by Lauren Dubinsky , Senior Reporter
Researchers at St. Michael’s Hospital in Toronto recently made the discovery that MR imaging can be used to measure kidney damage and predict the organ’s future function.

In a study published in the Clinical Journal of the American Society of Nephrology, the team used an MR test called an elastogram to measure kidney scarring in 17 individuals who underwent kidney transplants.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“We think that our MR test would be a useful add-on test because it estimates scarring severity in the entire kidney, rather in the very small piece of the kidney that is sampled by the biopsy,” Dr. Darren Yuen, a transplant nephrologist and scientist at St. Michael’s, told HCB News.

Needle biopsies are the current standard for evaluating kidney scarring, but the patient is required to take pain medication and take a day off from work and the procedure can also result in bleeding. The MR elastogram test can do that without having to go inside the body.

It maps the stiffness of kidney tissue in order to determine if scarring is present. Diabetes, high blood pressure, and kidney transplant rejection cause scarring, which is irreversible and can eventually lead to kidney failure.

The study found that the MR elastogram test yielded comparable results to a kidney biopsy, and was also able to detect the amount and location of the scarring throughout the entire organ. It also found that kidney stiffness predicted how well the kidney would function a year after the MR exam.

The test to measure stiffness relies on generating motion in the kidney and assessing the reaction of the tissue. Currently, that can only be done in a repeatable numerical and accurate way with MR and ultrasound.

“MR has shown superiority over ultrasound in accuracy of the test in measuring scarring in other organs besides the kidney, especially the liver, so we thought it would be better to use MRI for kidneys,” said Dr. Anish Kirpalani, the study’s lead author and radiologist and scientist at St. Michael’s.

MR would not replace biopsies, but it could be used as a supplemental test to provide a more comprehensive understanding of a patient’s kidney function, according to Yuen. With the MR test, physicians can gather information on patients whose risk of biopsy is too high to undergo the procedure.

The test can also be used to test new anti-scarring treatments. There are currently no anti-scarring drugs on the market because it’s difficult to rationalize performing multiple kidney biopsies for a pharmaceutical trial.

Back to HCB News
  Pages: 1

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED